Liver Cancer News

2024

September 2024

Spark Conversations This Liver Cancer Awareness Month

Fox Chase Cancer Center Researchers Show Adaptive Radiation Therapy Effectively Delivers Treatment For Liver Tumors in Study Presented at American Society For Radiation Oncology Meeting

LI-RADS Value As A Prognostic Tool In Patients At High Risk For Liver Cancer

Spotlight on Liver MRI: Diagnosing and Managing Hepatocellular Carcinoma

Baptist Health Treats First Liver Cancer Patients with Histotripsy

Video: Advanced HCC: Key Takeaways

NDA Resubmitted for Camrelizumab Plus Rivoceranib in Unresectable HCC

New Model Predicts the Hepatocellular Carcinoma Risk in Chronic Hepatitis B

Non-Invasive Method Can Help Predict Survival In Patients With Liver Cancer

Research Impact: School of Medicine Researcher Reduces Disparities For Liver Cancer Patients

Imfinzi Plus Imjudo Shows Significant Five-Year Survival Improvement in Unresectable Liver Cancer

Progression-Free Survival in Intermediate-Stage Hepatocellular Carcinoma

Single-Fraction Radiotherapy Improves Pain in Hepatic Cancer

Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally

USP26: Key Driver in HBV-Induced Liver Cancer

Q&A: Researchers Discuss Statin, Metformin, And Aspirin Use With Hepatocellular Carcinoma

Women With Liver Cancer Less Likely Than Men To Receive Liver Transplant

MD Anderson Cancer Center at Cooper Offers Noninvasive Histotripsy For Treating Liver Cancer

Eisai Accelerates Progress in Oncology Research with New Data at ESMO Congress 2024, Including First Interim Analysis Results from the Phase 3 LEAP-012 Trial

Non-Invasive Tests Predict Liver Cancer Risk in Hepatitis C Patients After SVR

Video: Health Headlines: Liquifying Liver Cancer Tumors

August 2024

Acceptable Liver Transplant Outcomes Seen After ICI Therapy For Liver Cancer

FDA Supports Phase 3 Plan for Amezalpat in Hepatocellular Carcinoma

Neoadjuvant Immunotherapy May Facilitate Surgery and Improve Outcomes for Patients With High-risk Liver Cancer

Sleep Pills May Not Enhance Quality of Life in Hepatocellular Carcinoma Patients

Study May Have Good News for Patients With Early-stage Liver Cancer

Overcoming Disparities In Hepatocellular Carcinoma Outcomes In First Nations Australians: A Strategic Plan For Action

Atezolizumab/Bevacizumab Represents Potential Therapeutic Option in Child-Pugh B7 HCC

Sleep Quality, Liver Function Biomarkers May Impact Liver Cancer Risk

New Evidence Supports Cholesterol Absorption Inhibitors in Liver Cancer Prevention

Transplant Possible After Immunotherapy for Advanced Liver Cancer Patients

CIRT Plus Durvalumab/Tremelimumab Is Safe in Advanced HCC With Macrovascular Invasion

Video: Liver Cancer And Why Scans Can Be Misleading

Phase 1 Study of MT-303 Doses First Patient With HCC

Liver Cancer Growth in Mice Is Linked to Essential Amino Acid

Addressing Ongoing Disparities in Liver Cancer Care: Dr Amit Singal

Myeloid Therapeutics Does First Subject In Hepatocellular Carcinoma Trial

Video: Patient Communication Strategies in Hepatocellular Carcinoma

Elevar Therapeutics Granted Orphan Medicinal Product Designation by the European Medicines Agency for First-Line Systemic Therapy for Unresectable Hepatocellular Carcinoma

July 2024

Myeloid Therapeutics Initiates Patient Dosing with MT-303, a Novel GPC3 Targeting RNA CAR, in Phase 1 Study for Advanced Hepatocellular Carcinoma

Liver Cancer Growth Tied To Tryptophan Intake

Advancing Hepatic Cell Carcinoma Treatment Through Mitochondrial DNA Targeting

Spotlight on Sylvester’s Liver Cancer Research

Adjuvant Immunotherapy for HCC: Where Are We and Where Are We Going?

Dr Franses on the Need for Prospective Data in Second-Line HCC and Beyond

Response to Immunotherapy Linked With Improved Liver Function in Advanced HCC

Treating HCC with Genetically Modified NK-cell Therapy

Dr Franses on Considerations for Second-Line Treatment of HCC

BMS Gains EMA Validation for Opdivo/Yervoy Combo in Liver Cancer

Post-Treatment Adjuvant Therapy for Liver Cancer: Questions Remain

Adjuvant Therapy For Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions

Ultrasonography Of Hepatocellular Carcinoma: From Diagnosis To Prognosis

Benefits of Hepatocellular Carcinoma Screening Continue After HCV Cure, Study Finds

Liver Tumor Microproteins Could Be Key to Developing New Cancer Vaccines

Stem Cell-Derived Therapy Shows Early Promise for Resistant Liver Cancer

Snapshots: Harnessing AI to Improve Care

Treatment Options For Hepatocellular Carcinoma Using Immunotherapy: Present And Future

June 2024

Robotic Liver Surgery Leads to Shorter Hospital Stays, Quicker Recovery

Medivir Presents Promising Results In Difficult-To-Treat Patient Population

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

Multi-Regional Sampling Uncovers Hidden Complexity In Liver Cancer

Can-Fite: Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver

Camrelizumab Plus Rivoceranib vs Sorafenib as First-Line Therapy for Unresectable Hepatocellular Carcinoma (uHCC): Final Overall Survival Analysis of the Phase 3 CARES-310 Study

Improving The Conversion Success Rate Of Hepatocellular Carcinoma

Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally

New Tool Could Spot Liver Cancer Early, Upping Survival

Coherus, Junshi’s PD-1 Blocker Loqtorzi Aces Phase III Liver Cancer Trial

Study Highlights Increasing Global Health Burden of Liver Cancer

Frontline Camrelizumab/Rivoceranib Prolongs OS vs Sorafenib in Unresectable HCC

HKUMed’s World-First ‘Liver-in-Cube’ Wins A Gold Medal At International Exhibition Of Inventions Of Geneva, Advancing Precise Cancer Treatment

Guideline Update Seeks to Aid Clinicians in the Selection of Systemic Treatments for Advanced Hepatocellular Carcinoma

New City of Hope Study Shows Liver Surgery to Remove Cancer Can Now Be a Safe, Outpatient Procedure

Liver Cancer Program Among the First in the Country to Offer Noninvasive Histotripsy for Destroying Cancerous Liver Tumors

Opdivo Plus Yervoy Shows Significantly Improved Survival Benefit Treating Advanced Hepatocellular Carcinoma

Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study

AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024

May 2024

First-Line Camrelizumab Plus Rivoceranib Maintains Survival Benefit in Unresectable HCC

AASLD Issues First Guidelines on Non-Invasive Liver Disease Assessments

Liver Lesions At Risk Of Transformation Into Hepatocellular Carcinoma In Cirrhotic Patients: Study

Transarterial Chemoembolization Plus Immune Checkpoint Blockade for Patients With Hepatocellular Carcinoma

Immunotherapy Shapes Present, Future Hepatocellular Carcinoma Treatments

FDA Sends CRL for Camrelizumab/Rivoceranib in Unresectable Liver Cancer

Wei Zhang, MD, PhD: Recognizing Disparities in Hepatocellular Carcinoma Diagnosis, Care

Screening Patients With HCC Risk Factors Linked With Reduced Mortality

Transomics’ Impact On A Promising Liver Cancer Therapeutic

Liver Cancer Screening Improves Survival but Is Underused

Lysyl oxidase-like 2 (LOXL2) Emerges as a Predictor of Liver Cancer Risk in HCV Patients After Successful Treatment

Video: Sugary Drinks Linked To High Risk Of Liver Cancer, Study Finds

Investigating Hepatitis B Virus-Related Hepatocellular Carcinoma Incidence

Can-Fite: 75 Oncologists and Coordinators from Europe US and Israel Participated in a Conference Aimed at Accelerating Patient Enrolment for the Pivotal Phase 3 Advanced Liver Cancer Study

Cytokeratins Could Aid Early Detection of Hepatocellular Carcinoma in Patients with HCV

New Study Reveals How Gender Affects Liver Transplant Success In Cancer Patients

Treating Transplant-Ineligible Patients With HCC and Liver-Confined Disease

Combo Therapy May Be Advance Against Liver Cancer

Metformin, Statins May Reduce Hepatocellular Carcinoma Risk After HCV Treatment Failure

Georgia Hospital Successfully Performs First Non-Invasive Liver Cancer Treatment In The State

Novel Blood Biomarkers Show Potential for Early Liver Cancer Diagnosis

Combined Therapy Makes Headway For Liver Cancer

April 2024

ASCO Updates Advanced HCC Treatment Guideline

Study Identifies Driver Of Liver Cancer That Could Be Target For Treatment

New Nanoprodrug System Created to Treat Liver Cancer

Dr Michael Morse on the Etiologies of HCC and Treatment Options for Patients With Worsening Liver Function

In Hepatocellular Carcinoma, What Role for Adjuvant Radiotherapy?

Enhancing Hepatocellular Carcinoma Surveillance: A Community-Based Approach

Targeted Liver Cancer Treatment Kills Cancer Cells And Cuts Chemo Side Effects

Cleveland Clinic Uses Noninvasive Ultrasound Technology to Treat Some Liver Tumors

Personalized Anti-Tumor Vaccine Enhances Immunotherapy For Liver Cancer

Geneos Cancer Vaccine Shrinks Liver Tumors In Small Trial

Treating Early- and Intermediate-Stage Hepatocellular Carcinoma

March 2024

NYU Langone Cancer Specialists Use Pioneering Histotripsy Technology to Noninvasively Treat Liver Tumors

Innovative Yttrium-90 Radioisotopes Revolutionize Liver Cancer Treatment

ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm

Liver Cancer Death Rates Have Stabilized in the US

Machine Learning Model Predicts Hepatocellular Carcinoma Risk in Patients With MASLD

Opdivo plus Yervoy Shows Survival Benefit in Patients with Hepatocellular Carcinoma in Phase III CheckMate -9DW Trial

Immune Evasion Tactics Of Liver Cancer Cells Revealed

First-Line Nivolumab/Ipilimumab Improves Survival in Hepatocellular Cancer

Podcast: Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline Update

Immune Evasion Tactics Of Liver Cancer Cells Revealed

Georgia Hospital Is The First And Only In State To Offer Non-Invasive Liver Cancer Treatment

Maternal Obesity Linked To Liver Cancer Risk In Offspring

A Pioneering Way To Target The Culprit Behind A Deadly Liver Cancer

Study Finds Increasing Hepatocellular Carcinoma Incidence, Mortality in the US

Video: Cancer Conversation Liver Cancer

Possible Tumor Marker Found For The Development Of Hepatocellular Carcinoma

Rising Alcohol-Related Liver Cancer Prompts New Prediction Tool

February 2024

UC Davis Health Team Uses AI To Predict Risk Of Liver Cancer

Evolving Treatments in Hepatocellular Carcinoma: Updates from ASCO GI 2024

Old Vaccine Potentially Treats Liver Cancer

Hepatocellular Carcinoma Incidence And Mortality In The US By Sex, Age, And Race

Immune-Onc Collaborates with Roche for Liver Cancer Treatment Trial

TB Vaccine Shrinks Liver Cancer Tumors In Mice

Iterion Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of Tegavivint in Patients with Advanced Hepatocellular Carcinoma Who Have Failed One or More Systemic Treatments

AASLD Guidance on Liver Cancer Management

Liver Cancer: A Promising Avenue for More Effective Immunotherapies

Achieving SVR May Not Reduce Risk of HCC in Patients with HCV

Evidence-Based Nursing Achieves Better Postsurgical Outcomes in Liver Cancer

Blood Biomarkers in TGF-β Pathway Identify Hidden Liver Cancer Risk

Study Suggests The Possibility Of Combination Therapy Of SORA and FGF21 In Hepatocellular Carcinoma

Korea University Researchers Unveil Benefits Of Perioperative Radiotherapy For Treating Liver Cancer With High Recurrence Risk

Liver Cancer Impact In Mississippi Among Largest In US

FDA Fast Tracks BST02 for Liver Cancer

Diabetes And Liver Cancer — Stanford Medicine Study Suggests New Screening Guidelines

January 2024

Postoperative IMRT Improves RFS in Hepatocellular Carcinoma

Adding Immunotherapy to Local Treatment Delays Liver Cancer Progression

Oncofetal Ecosystems Linked To Recurrence And Immunotherapy Response In Liver Cancer

Video: Hope for Patients with Hepatocellular Carcinoma

What Patients With Liver Cancer Need to Know About Hepatitis B and C

AstraZeneca's (AZN) Imfinzi Combo Meets Liver Cancer Study Goal

Haystack Oncology, Developer of Haystack MRD™, and TriSalus Life Sciences collaborate In Connection With The Clinical Development Of Trisalus' TLR9 Agonist In Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, And Pancreatic Adenocarcinoma

Poor Liver Function Can Cause Side Effects, Drug Discontinuation in HCC

Pembrolizumab Combo Improves PFS/OS in Hepatocellular Carcinoma

Lenvatinib Combo Yields Safety, Disease Control in Hepatocellular Carcinoma

Hepatitis Treatments Underutilized Among ‘Sickest’ With Liver Cancer

Regorafenib Discontinuation More Likely With Poor Liver Function in Liver Cancer

Dr. Kim on Ongoing and Planned Research in HCC at Moffitt Cancer Center

Fostrox + Lenvima Shows Further Improved Response Rates and Time to Progression in Advanced Liver Cancer (HCC) at ASCO GI Symposium

Patient Adherence To Ultrasound Liver Cancer Surveillance Recs Is Low

Carsgen Therapeutics Cleared to Study Cell Therapy in Certain Liver Cancer Patients in China

The Search Continues for Viable Biomarkers in Hepatocellular Carcinoma

Antiviral Therapy Found to Improve Long-Term Survival for Patients With HBV- and HCV-Related Hepatocellular Carcinoma

Dr. Kim on Selecting Between Frontline Immunotherapy-Based Regimens in HCC

Black People With Liver Cancer Are Less Likely To Receive Liver Transplants

Analysis Shows Increases in HCV-Related Liver Cancer, Mortality

New Technique Uses Microscopic Bubbles to Blast Cancer With Help From GI Research Foundation

New Discoveries and Potential Therapies for Liver Cancer: A Comprehensive Look

Revolutionary Study Reveals Lactobacillus Acidophilus Could Ward Off Liver Cancer Linked To Fatty Liver Disease

Dr. Kim on a Case Study of a Patient With HCC

Mailed Outreach Doubles Hepatocellular Carcinoma (HCC) Surveillance Imaging Uptake

SERS Used to Detect Early-Stage Liver Cancer

Silent Enemy: Alcohol And Liver Cancer

Future Directions in the Management of Hepatocellular Carcinoma

AI Offers Promise For Accurate Liver Cancer Diagnosis

For past liver cancer news, please visit our Liver Cancer News Archives.